Back to Journals » Breast Cancer: Targets and Therapy » Volume 15
Breast Cancer: Targets and Therapy
ISSN: 1179-1314
- View all (489)
- Volume 16, 2024 (18)
- Volume 15, 2023 (79)
- Volume 14, 2022 (41)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Archive: Volume 15, 2023
- default (79)
- Targeting Triple-Negative Breast Cancers: Modern Advancements and Future Directions (3)
CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1
Zhu X, Yu J, Ai F, Wang Y, Lv W, Yu G, Cao X, Lin J
Breast Cancer: Targets and Therapy 2023, 15:967-984
Published Date: 28 December 2023
Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy
Kim JY, Yang DW, Kim S, Choi JG
Breast Cancer: Targets and Therapy 2023, 15:955-966
Published Date: 21 December 2023
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]
Wardoyo S, Fadillah MA, Hamtini
Breast Cancer: Targets and Therapy 2023, 15:953-954
Published Date: 19 December 2023
Immunotherapy: Constructive Approach for Breast Cancer Treatment
Anayyat U, Ahad F, Muluh TA, Zaidi SAA, Usmani F, Yang H, Li M, Hassan HA, Wang X
Breast Cancer: Targets and Therapy 2023, 15:925-951
Published Date: 15 December 2023
Breast Cancer Awareness Among Women in Saudi Arabia: A Systematic Review
AlRajhi B, Aljadani FF, Almarwan SR, Alzahrani AA, Sindi MHM, Kano A, Alzahrani RS, Baaqeel R
Breast Cancer: Targets and Therapy 2023, 15:913-924
Published Date: 14 December 2023
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models
Hu W, Wang L, Luo J, Zhang J, Li N
Breast Cancer: Targets and Therapy 2023, 15:899-912
Published Date: 8 December 2023
Accuracy Rate of Methylene Blue Injection in Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Patients: A Prospective Observational Study
Aziz HK, Azhar Y, Widarda IR, Abdurahman M, Erdiansyah Z, Nugraha P, Lukman K
Breast Cancer: Targets and Therapy 2023, 15:891-897
Published Date: 7 December 2023
Evaluation of Cytotoxicity of the Methanolic Extract of Red Sea Marine Sponge Xestospongia Testudinaria and Its Related Compounds Against MCF-7 Human Breast Cancer Cells
Alkhilaiwi FA, Fadil SA, Aljoud FA, Yonbawi AR, Ashi A, Hareeri RH, Bakhashab S, Alamri AM, Albikairi AY, Shaala LA, El-Gamal AA, Youssef DT
Breast Cancer: Targets and Therapy 2023, 15:879-890
Published Date: 7 December 2023
Nomogram Based on Super-Resolution Ultrasound Images Outperforms in Predicting Benign and Malignant Breast Lesions
Yang L, Ma Z
Breast Cancer: Targets and Therapy 2023, 15:867-878
Published Date: 2 December 2023
Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody–Drug Conjugate Therapy
Goyal RK, Zhang J, Davis KL, Sluga-O'Callaghan M, Kaufman PA
Breast Cancer: Targets and Therapy 2023, 15:855-865
Published Date: 17 November 2023
Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases
Huang J, Zhu W, Duan Q, Zhu C, Shi X, Zhao H, Cai P, Li D
Breast Cancer: Targets and Therapy 2023, 15:841-853
Published Date: 17 November 2023
The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications
Li J, He D, Bi Y, Liu S
Breast Cancer: Targets and Therapy 2023, 15:825-840
Published Date: 16 November 2023
Psychometric Properties and Factorial Analysis of the Arabic McGill-QoL Questionnaire in Breast Cancer
Omar MTA, Alnahdi AH
Breast Cancer: Targets and Therapy 2023, 15:813-824
Published Date: 14 November 2023
ABCB1 Regulates Immune Genes in Breast Cancer
Chen HK, Chen YL, Wang CY, Chung WP, Fang JH, Lai MD, Hsu HP
Breast Cancer: Targets and Therapy 2023, 15:801-811
Published Date: 13 November 2023
Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
Dakroub R, Huard S, Hajj-Younes Y, Suresh S, Badran B, Fayyad-Kazan H, Dubois T
Breast Cancer: Targets and Therapy 2023, 15:785-799
Published Date: 6 November 2023
Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
Gorenšek R, Kresnik M, Takač I, Rojko T, Sobočan M
Breast Cancer: Targets and Therapy 2023, 15:773-783
Published Date: 2 November 2023
A Review on the Management of Peripheral Neuropathic Pain Following Breast Cancer
Avila F, Torres-Guzman R, Maita K, Garcia JP, De Sario GD, Borna S, Ho OA, Forte AJ
Breast Cancer: Targets and Therapy 2023, 15:761-772
Published Date: 30 October 2023
Traditional Chinese Medicine for Breast Cancer: A Review
Feng RQ, Li DH, Liu XK, Zhao XH, Wen QE, Yang Y
Breast Cancer: Targets and Therapy 2023, 15:747-759
Published Date: 27 October 2023
PDL1-Based Nomogram May Be of Potential Clinical Utility for Predicting Survival Outcome in Stage III Breast Cancer
Zhang X, Li R, Wang G
Breast Cancer: Targets and Therapy 2023, 15:731-746
Published Date: 25 October 2023
Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives
Wang J, Wu SG
Breast Cancer: Targets and Therapy 2023, 15:721-730
Published Date: 20 October 2023
A Comprehensive Model Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging Can Better Predict the Preoperative Histological Grade of Breast Cancer Than a Radiomics Model
Wu Y, Pan W, Wang L, Pan W, Zhang H, Jin S, Wu X, Liu A, Xin E, Ji W
Breast Cancer: Targets and Therapy 2023, 15:709-720
Published Date: 18 October 2023
Hsa_circ_0007823 Overexpression Suppresses the Progression of Triple-Negative Breast Cancer via Regulating miR-182-5p-FOXO1 Axis
Yu J, Wang H, Shen W, Zhou Y, Cui J, Li H, Gao B
Breast Cancer: Targets and Therapy 2023, 15:695-708
Published Date: 18 October 2023
The Impact of Deep Inspiration Breath Hold (DIBH) Implementation on the Hybrid Technique in Left-Sided Whole Breast Irradiation: A Dosimetric Characteristic Study of 3D-CRT Hybrid VMAT in DIBH and Free Breathing Conditions, and VMAT in Free Breathing Conditions
Yeh HL, Lin JF
Breast Cancer: Targets and Therapy 2023, 15:683-693
Published Date: 12 October 2023
Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study
Chen X, Qian X, Xiao M, Zhang P
Breast Cancer: Targets and Therapy 2023, 15:671-682
Published Date: 4 September 2023
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T, Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V
Breast Cancer: Targets and Therapy 2023, 15:659-669
Published Date: 1 September 2023
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
Tong L, Yu X, Wang S, Chen L, Wu Y
Breast Cancer: Targets and Therapy 2023, 15:647-658
Published Date: 24 August 2023
Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan
Haque R, Chen LH, Oestreicher N, Lalla D, Chlebowski RT
Breast Cancer: Targets and Therapy 2023, 15:637-645
Published Date: 16 August 2023
ABVS-Based Radiomics for Early Predicting the Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancers
Jiang W, Deng X, Zhu T, Fang J, Li J
Breast Cancer: Targets and Therapy 2023, 15:625-636
Published Date: 15 August 2023
Diagnostic Value of a Combined Serum α-Hydroxybutyrate Dehydrogenase, Carcinoembryonic Antigen and Glycoantigen 125 Test for Early-Stage Breast Cancer
Zhan CH, Liu GJ
Breast Cancer: Targets and Therapy 2023, 15:617-623
Published Date: 15 August 2023
HER2-Low Breast Cancer: Current Landscape and Future Prospects
Shirman Y, Lubovsky S, Shai A
Breast Cancer: Targets and Therapy 2023, 15:605-616
Published Date: 14 August 2023
Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy
Fan J, Tang Y, Wang K, Yang S, Ma B
Breast Cancer: Targets and Therapy 2023, 15:591-604
Published Date: 11 August 2023
Popularity of Traditional Chinese Medicine Use Among Breast Cancer Patients in North China: A Cross-Sectional Study
Zhao R, Zhang J, Gou Q, Gao J
Breast Cancer: Targets and Therapy 2023, 15:577-589
Published Date: 10 August 2023
Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing
Bai Q, Lv H, Bao L, Yang Y, Zhang X, Chang H, Xue T, Ren M, Zhu X, Zhou X, Yang W
Breast Cancer: Targets and Therapy 2023, 15:563-575
Published Date: 3 August 2023
Clinicopathological Risk Factors of Unfavorable Outcomes in Vietnamese Women with Primary Invasive Breast Cancer: A Retrospective Cohort Study
Huynh CG, Huynh NX, Truong BHT, Thai TT, Doan PTT
Breast Cancer: Targets and Therapy 2023, 15:551-561
Published Date: 1 August 2023
Early but Quality Diagnosis: On Breast Cancer and Its Risk Factors [Letter]
Zehra SS, Turabee Z, Rawalia MA
Breast Cancer: Targets and Therapy 2023, 15:549-550
Published Date: 1 August 2023
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib
Sharaf B, Abu-Fares H, Tamimi F, Al-Sawajneh S, Salama O, Daoud R, Alhajahjeh A, Al-Lababidi S, Abdel-Razeq H
Breast Cancer: Targets and Therapy 2023, 15:541-548
Published Date: 28 July 2023
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
Höller A, Nguyen-Sträuli BD, Frauchiger-Heuer H, Ring A
Breast Cancer: Targets and Therapy 2023, 15:525-540
Published Date: 28 July 2023
Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression
Purwanto I, Leo B, Hutajulu SH, Kurnianda J, Taroeno-Hariadi KW, Hardianti MS, Satiti AD, Dwianingsih EK, Heriyanto DS, Widodo I, Aryandono T
Breast Cancer: Targets and Therapy 2023, 15:515-524
Published Date: 27 July 2023
Perceived Barriers and Facilitators to Breast Cancer Screening Among Women in Saudi Arabia
AlAbdulKader A, Gari D, Al yousif G, Alghamdi A, AlKaltham S, AlDamigh F, AlEisawi Y, AlGhamdi A, Al-Hayek O, AlMudhi A
Breast Cancer: Targets and Therapy 2023, 15:505-513
Published Date: 25 July 2023
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery
Ni Y, Deng F, Yu S, Zhang J, Zhang X, Huang D, Zhou H
Breast Cancer: Targets and Therapy 2023, 15:495-504
Published Date: 25 July 2023
PRO Hair Safe Study: The Patient’s Perspective on the Effects of Scalp Cooling on Hair Preservation
Brunner C, Egle D, Ritter M, Kofler R, Giesinger JM, Schneitter L, Sztankay M, Emmelheinz M, Abdel Azim S, Wieser V, Oberguggenberger A
Breast Cancer: Targets and Therapy 2023, 15:485-494
Published Date: 17 July 2023
On Ultrasonographic Features of Mucinous Carcinoma with Micropapillary Pattern
Yang WS, Li Y, Gao Y
Breast Cancer: Targets and Therapy 2023, 15:473-483
Published Date: 17 July 2023
Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
Huang Y, Guo Y, Xiao Q, Liang S, Yu Q, Qian L, Zhou J, Le J, Pei Y, Wang L, Chang C, Chen S, Zhou S
Breast Cancer: Targets and Therapy 2023, 15:461-472
Published Date: 11 July 2023
A Cross-Sectional Evaluation of Knowledge About Breast Cancer and Perceived Barriers to the Uptake of Mammogram Screening Among Northern Saudi Women: A Population-Based Study
Alanazi MF, Thirunavukkarasu A, Alrowily M, Alaqel N, Alaqel A, Alruwaili M, Alazmi NNM, Alhassan O, Aljarallah MFM, Altaymani AM
Breast Cancer: Targets and Therapy 2023, 15:451-460
Published Date: 10 July 2023
Promoter Methylation-Regulated Differentially Expressed Genes in Breast Cancer
Sindi S, Hamdi N, Hassan S, Ganash M, Alharbi M, Alburae N, Azhari S, Alkhayyat S, Linjawi A, Alkhatabi H, Elaimi A, Alrefaei G, Alsubhi N, Alrafiah A, Alhazmi S
Breast Cancer: Targets and Therapy 2023, 15:435-450
Published Date: 6 July 2023
Pregnancy Associated Invasive Apocrine Carcinoma of the Breast: Case Report from Ethiopia
Alemu HK, Hammad N, Tola MA, Vanderpuye V
Breast Cancer: Targets and Therapy 2023, 15:429-433
Published Date: 23 June 2023
Detecting the Frequency of c.5946delT Pathogenic Variant in the BRCA2 Gene and Associated Risk Factors Among Breast Cancer Patients Visiting Felege Hiwot Referral Hospital and University of Gondar Comprehensive Specialized Hospital
Berhane N, Chekol Z, Seid A
Breast Cancer: Targets and Therapy 2023, 15:421-427
Published Date: 19 June 2023
Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis
Liu Y, Tang J, Qiu X, Teng LA, Sriwastva MK, Han X, Li Z, Liu M, Liu S, Da D, Li Z, Zhen L, Ren Y
Breast Cancer: Targets and Therapy 2023, 15:403-419
Published Date: 30 May 2023
Transcriptome Profiling Analysis of Breast Cancer Cell MCF-7 Treated by Sesamol
Wu J, Luo D, Xu J
Breast Cancer: Targets and Therapy 2023, 15:391-401
Published Date: 29 May 2023
Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography
Ma Q, Shen C, Gao Y, Duan Y, Li W, Lu G, Qin X, Zhang C, Wang J
Breast Cancer: Targets and Therapy 2023, 15:381-390
Published Date: 26 May 2023
ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion
Ahmad SMS, Nazar H, Rahman MM, Rusyniak RS, Ouhtit A
Breast Cancer: Targets and Therapy 2023, 15:373-380
Published Date: 24 May 2023
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
Dubrava AL, Kyaw PSP, Newman J, Pringle J, Westhuyzen J, La Hera Fuentes G, Shakespeare TP, Sakalkale R, Aherne NJ
Breast Cancer: Targets and Therapy 2023, 15:359-371
Published Date: 11 May 2023
Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review
Alghamdi MAA, Esam Mahmood S
Breast Cancer: Targets and Therapy 2023, 15:349-358
Published Date: 9 May 2023
Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications
da Silva JL, Carvalho GDS, Zanetti de Albuquerque L, Rodrigues FR, Fernandes PV, Kischinhevsky D, de Melo AC
Breast Cancer: Targets and Therapy 2023, 15:337-347
Published Date: 8 May 2023
Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses
Jin Y, Lan A, Dai Y, Jiang L, Liu S
Breast Cancer: Targets and Therapy 2023, 15:327-335
Published Date: 1 May 2023
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O
Breast Cancer: Targets and Therapy 2023, 15:311-325
Published Date: 27 April 2023
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
Shen J, Yan H, Yang C, Lin H, Li F, Zhou J
Breast Cancer: Targets and Therapy 2023, 15:295-310
Published Date: 25 April 2023
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review
Wang J, Liao D, Zhang X, Miao C, Chen K
Breast Cancer: Targets and Therapy 2023, 15:281-294
Published Date: 21 April 2023
Breast Cancer Awareness Among Medical Students, University of Bisha, Saudi Arabia
Miskeen E, Al-Shahrani AM
Breast Cancer: Targets and Therapy 2023, 15:271-279
Published Date: 17 April 2023
Psychosocial Problems of Rural Indian Women Practising Breast Self-Examination – a Community-Based Study from Southern India
Balaiah Mehanathan P, Arthur Edwards Dennison A, Vikramathithan Panchapooranam A, Kandasamy S, Subbiah P, Velappan L, Kalyanaraman S
Breast Cancer: Targets and Therapy 2023, 15:263-270
Published Date: 17 April 2023
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study
Koo DH, Lee KS, Sim SH, Chae H, Lee EG, Han JH, Jung SY, Lee S, Kang HS, Lee ES, Park CY, Oh SW
Breast Cancer: Targets and Therapy 2023, 15:251-261
Published Date: 14 April 2023
Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study
Sherwani M, Vohra L, Ali D, Soomro R, Adnan S, Idrees R
Breast Cancer: Targets and Therapy 2023, 15:237-250
Published Date: 27 March 2023
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
Satish S, Moore JF, Littlefield JM, Bishop IJ, Rojas KE
Breast Cancer: Targets and Therapy 2023, 15:227-235
Published Date: 22 March 2023
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis
Huo Q, Ning L, Xie N
Breast Cancer: Targets and Therapy 2023, 15:213-226
Published Date: 10 March 2023
Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
Castellanos G, Valbuena DS, Pérez E, Villegas VE, Rondón-Lagos M
Breast Cancer: Targets and Therapy 2023, 15:189-211
Published Date: 9 March 2023
Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis
Cao Q, Ai XQ, Mushajiang M
Breast Cancer: Targets and Therapy 2023, 15:175-188
Published Date: 9 March 2023
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
Emiroglu S, Özkurt E, Cabıoglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M, Tukenmez M
Breast Cancer: Targets and Therapy 2023, 15:163-173
Published Date: 21 February 2023
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?
Jongbloed EM, Blommestein HM, van Schoubroeck HM, Martens JW, Wilting SM, Uyl-de Groot CA, Jager A
Breast Cancer: Targets and Therapy 2023, 15:147-161
Published Date: 16 February 2023
The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis
Liao Y, Liao Y, Li J, Li Y, Fan Y
Breast Cancer: Targets and Therapy 2023, 15:135-146
Published Date: 11 February 2023
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Response to Letter]
AlSumai TS, Alhefdhi A
Breast Cancer: Targets and Therapy 2023, 15:133-134
Published Date: 6 February 2023
Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer
Li N, Song C, Huang X, Zhang H, Su J, Yang L, He J, Cui G
Breast Cancer: Targets and Therapy 2023, 15:121-132
Published Date: 5 February 2023
An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
Zhang M, Bao S, Qiu G, Liang J, Wang Q, Zhu X, Qin G, Liu J, Zhao C
Breast Cancer: Targets and Therapy 2023, 15:101-119
Published Date: 3 February 2023
Assessment of Knowledge and Awareness About Breast Self-Examination Among University Female Students in Saudi Arabia
Albeshan S, Shubayr N, Alashban Y
Breast Cancer: Targets and Therapy 2023, 15:91-99
Published Date: 1 February 2023
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications
Prodhan ASU, Islam DZ, Khandker SS, Jamiruddin MR, Abdullah A, Godman B, Opanga S, Kumar S, Sharma P, Adnan N, Pisana A, Haque M
Breast Cancer: Targets and Therapy 2023, 15:51-89
Published Date: 27 January 2023
Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review
Badran O, Abu Amna M, Turgeman I, Bar-Sela G
Breast Cancer: Targets and Therapy 2023, 15:47-50
Published Date: 24 January 2023
Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review
Wu J, Jin Y, Liu M, Zhu N, Jing Z, Zeng X
Breast Cancer: Targets and Therapy 2023, 15:39-45
Published Date: 19 January 2023
Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques
Zhang Q, Zeng Y, Peng Y, Yu H, Zhang S, Wu S
Breast Cancer: Targets and Therapy 2023, 15:25-38
Published Date: 23 January 2023
Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
Ma J, Dong C, Cao YZ, Ma BL
Breast Cancer: Targets and Therapy 2023, 15:11-24
Published Date: 17 January 2023
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer
Abdel-Razeq H, Abujamous L, Al-Azzam K, Abu-Fares H, Bani Hani H, Alkyam M, Sharaf B, Elemian S, Tamimi F, Abuhijla F, Edaily S, Salama O, Abdulelah H, Daoud R, Abubaker M, Al-Atary A
Breast Cancer: Targets and Therapy 2023, 15:1-10
Published Date: 13 January 2023